Roche Holding AG
0QQ6.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$352.94B
Close$
$362.87
1.9% downside
Current Fair Value
1.9% downsideOvervalued by 1.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $352.94 Billion |
|---|---|
| Enterprise Value | $379.15 Billion |
| Dividend Yield | $10.80 (2.74%) |
| Earnings per Share | $15.92 |
| Beta | 0.35 |
| Outstanding Shares | 809,257,000 |
Return
| Return on Equity | 66.85% |
|---|---|
| Return on Assets | 22.26% |
| Return on Invested Capital | 42.92% |
Valuation & Multiples
| P/E Ratio | 23.29 |
|---|---|
| PEG | -298.84 |
| Price to Sales | 2.43 |
| Price to Book Ratio | 8.22 |
| Enterprise Value to Revenue | 3.07 |
| Enterprise Value to EBIT | 12.81 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.97 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 23, 2026
EPS Estimate
$10.11
Average shareholder expectationRevenue Estimate
$30.43 B
Average shareholder expectationNext Earnings Call
Expected Date
February 4, 2027
EPS Estimate
$9.43
Average shareholder expectationRevenue Estimate
$32.53 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Roche Holding AG
103,249 employees
CEO: Severin Schwan Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ...